| NCT ID | NCT06077253 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Aarhus |
| Condition | Primary Angle Glaucoma Closure Suspect |
| Study Type | INTERVENTIONAL |
| Enrollment | 242 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2029-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 242 participants in total. It began in 2023-09-01 with a primary completion date of 2029-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine whether primary angle closure suspects (PACS) in a Caucasian population benefit from prophylactic laser iridotomy.
Eligibility Criteria
Inclusion Criteria: * Primary angle closure suspect: ≥180 degrees (cumulative) irido-trabecular contact on darkroom gonioscopy, IOP\<21mmHg, no peripheral anterior synechiae, no glaucomatous optic neuropathy * Best-corrected visual acuity (BCVA) \>0.8 on both eyes * Caucasian Exclusion Criteria: * Pseudophakia * Previous iridotomy * Clinically significant cataract with indication for surgery, * Gaucoma * Uveitis * Unstable retinal conditions * Ocular malignancies * PEX * PDS * Systemic or ocular corticosteroid treatment
Contact & Investigator
Niklas Telinius
PRINCIPAL INVESTIGATOR
Aarhus University Hospital
Frequently Asked Questions
Who can join the NCT06077253 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Primary Angle Glaucoma Closure Suspect. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06077253 currently recruiting?
Yes, NCT06077253 is actively recruiting participants. Contact the research team at telinius@me.com for enrollment information.
Where is the NCT06077253 trial being conducted?
This trial is being conducted at Aalborg, Denmark, Aarhus, Denmark, Glostrup Municipality, Denmark, Odense, Denmark and 1 additional location.
Who is sponsoring the NCT06077253 clinical trial?
NCT06077253 is sponsored by University of Aarhus. The principal investigator is Niklas Telinius at Aarhus University Hospital. The trial plans to enroll 242 participants.